Natural Alternatives International, Inc. (NAII) financial statements (2022 and earlier)

Company profile

Business Address 1535 FARADAY AVENUE
CARLSBAD, CA 92008-7319
State of Incorp. DE
Fiscal Year End June 30
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,35220,02832,13328,08928,62927,36630,478
Cash and cash equivalents19,35220,02832,13328,08928,62927,36630,478
Receivables15,06520,24519,04118,06817,26220,62617,849
Inventory, net of allowances, customer advances and progress billings31,82831,70927,00629,08834,46635,16527,972
Inventory31,82831,70927,00629,08834,46635,16527,972
Derivative instruments and hedges, assets1,8311,173    450
Other undisclosed current assets2,4852,0812,1681,9803,0603,2532,275
Total current assets:70,56175,23680,34877,22583,41786,41079,024
Noncurrent Assets
Operating lease, right-of-use asset14,54215,21215,87716,55117,03417,69618,354
Property, plant and equipment39,74139,50422,27122,45622,40922,03921,523
Deferred income tax assets  2146801,2621,004196
Other noncurrent assets2,5142,2111,5711,5491,3971,4071,106
Total noncurrent assets:56,79756,92739,93341,23642,10242,14641,179
TOTAL ASSETS:127,358132,163120,281118,461125,519128,556120,203
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,56918,17819,53722,45019,50424,62617,806
Accounts payable10,13713,01211,89315,29912,37717,76912,509
Accrued liabilities1,5211,3102,4412,9182,8093,0141,627
Employee-related liabilities2,6332,6904,5843,3712,3302,2072,660
Taxes payable1,2781,1666198621,9881,6361,010
Deferred revenue6221,9411,721    
Debt298296  10,00010,00010,000
Derivative instruments and hedges, liabilities 748149543,1842,507 
Other liabilities 135     
Total current liabilities:16,48920,62422,07223,40432,68837,13327,806
Noncurrent Liabilities
Long-term debt and lease obligation24,78525,44116,48117,02617,95618,33018,782
Long-term debt, excluding current maturities9,6349,704     
Operating lease, liability15,15115,73716,48117,02617,95618,33018,782
Liabilities, other than long-term debt1,6831,5931,6452,0072,3871,9622,240
Accounts payable and accrued liabilities1,1181,1181,2501,2501,2501,2501,349
Deferred income tax liabilities15775     
Liability, pension and other postretirement and postemployment benefits408400391757734712696
Derivative instruments and hedges, liabilities  4 403 195
Total noncurrent liabilities:26,46827,03418,12619,03320,34320,29221,022
Total liabilities:42,95747,65840,19842,43753,03157,42548,828
Stockholders' equity
Stockholders' equity attributable to parent84,40184,50580,08376,02472,48871,13171,375
Common stock88888889888787
Treasury stock, value(18,386)(15,859)(15,849)(15,842)(15,203)(13,445)(11,702)
Additional paid in capital29,92329,67829,45629,02228,68928,35327,992
Accumulated other comprehensive income (loss)724393(561)(1,232)(3,157)(2,303)(1,183)
Retained earnings72,05270,20566,94963,98762,07158,43956,181
Total stockholders' equity:84,40184,50580,08376,02472,48871,13171,375
TOTAL LIABILITIES AND EQUITY:127,358132,163120,281118,461125,519128,556120,203

Income statement (P&L) ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
Revenues37,72738,34044,39146,32048,08339,72635,096
Cost of revenue
(Cost of Goods and Services Sold)
(31,181)(30,059)(36,464)(39,484)(38,409)(33,721)(28,564)
Gross profit:6,5468,2817,9276,8369,6746,0056,532
Operating expenses(4,145)(4,053)(4,432)(4,136)(4,282)(3,920)(4,461)
Operating income:2,4014,2283,4952,7005,3922,0852,071
Nonoperating expense(9)(26)(94)(326)(806)(321)(234)
Foreign currency transaction gain (loss), before tax11(6)(87)(304)(753)(265)(176)
Other nonoperating income (expense)(7)(7)1(7)(5)(10)(8)
Income from continuing operations before income taxes:2,3924,2023,4012,3744,5861,7641,837
Income tax expense (benefit)(545)(946)(439)(458)(954)494(39)
Net income available to common stockholders, diluted:1,8473,2562,9621,9163,6322,2581,798

Comprehensive Income ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
Net income:1,8473,2562,9621,9163,6322,2581,798
Other undisclosed comprehensive income (loss)  460   (424)
Comprehensive income:1,8473,2563,4221,9163,6322,2581,374
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3319542111,925(854)(1,120)(742)
Comprehensive income, net of tax, attributable to parent:2,1784,2103,6333,8412,7781,138632

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: